In CRC, the COL11A1 gene is excessively expressed and contributes to tumor advancement by upregulating other genes like THBS2, COL10A1, COL5A2, and COL1A2, thereby driving neoplasia[46]. The gene discussed is THBS2; the disease is neoplasm.